Consensus Nykode Therapeutics

Equities

Market Closed - Oslo Bors Other stock markets 10:45:00 2024-05-10 am EDT			5-day change	1st Jan Change
14.04 ^NOK	+3.16%		+1.45%	-34.39%

Apr. 19	Nykode Therapeutics Launches Phase 2 Clinical Trial for Cervical Cancer Vaccine	MT
Apr. 19	Nykode Therapeutics ASA Initiates Phase 2 Trial of VB10.16 in Second Line HPV16-Positive Cervical Cancer	CI

c0c6c011a8a63.DHy9bGSqfvK9rChcBnko4LhyQl_mK1mgHiDwF3BeuEU.dSv6Oy7uG56Fm2EeYg9Glc4_JyaEBhiRS2WCYwka6SA1K-lUHYc4iOqBSw~fb3d463d9365436bacd0d63cf05f4b32

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

14.04 NOK

Average target price

43 NOK

Spread / Average Target

+206.27%

High Price Target

70 NOK

Spread / Highest target

+398.58%

Low Price Target

28 NOK

Spread / Lowest Target

+99.43%

Trading Rating

Investor Rating

ESG Refinitiv